Skip to content

About
Platform
- Platform Overview
- Quality and Reliability
Neuroscience
- Neuroscience Program
- IPI Publications
Protein Tools
- Commercial Antibody Collections
- Community Access Antibody Program (CAAP)
Education
News
Contact Us

Open mobile menuClose mobile menu

Cart

Antibody development against μ-opioid receptor

Nirakar Basnet, Murali Anuganti, Haiying Li, Deepash Kothiwal, Matt Salotto, Anita Ghosh, Roushu Zhang, Haisun Zhu, Rob Meijers, Shaotong Zhu

Antibody development against μ-opioid receptor

previous post: High throughput kinetic characterization of synthetic recombinant antibodies for various cell surface receptor targets
next post: Automated and high-throughput antibody production, validation and characterization at the Institute for Protein Innovation (IPI)

ABOUT

The Institute for Protein Innovation is pioneering a new approach to scientific discovery and collaboration. As a nonprofit research institute, we provide the biomedical research community with synthetic antibodies and deep protein expertise, empowering scientists to explore fundamental biological processes and pinpoint new targets for therapeutic development. Our mission is to advance protein science to accelerate research and improve human health.

LinkedIn
Bluesky
Instagram
YouTube

MENU

About IPI
Platform
Neuroscience
Protein Tools
Education
News
Careers
Contact Us

LOCATE US

Institute for Protein Innovation
4 Blackfan Circle, Room 921
Boston, MA 02115

EMAIL SIGNUP

* indicates required

Email Address *

First Name *

Last Name *

What types of emails would you like to receive?

Events
Newsletters

FCOI Policy Effort Reporting Policy Allowable and Unallowable Costs Policy
© 2026 Institute for Protein Innovation. All rights reserved.